Addex Therapeutics Ltd. (ADXN) stock
ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.47+0.07 (+2.06%)
Close on Nov 20, 2026Market cap $71.25KP/E –Yield –
Addex Therapeutics net income
Net income is the profit left for shareholders after every expense, interest and tax.
No net income figures for Addex Therapeutics
Addex Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?